{"id":60487,"date":"2024-02-28T06:51:06","date_gmt":"2024-02-28T06:51:06","guid":{"rendered":"https:\/\/medsname.com\/rofaday\/"},"modified":"2026-04-30T10:23:46","modified_gmt":"2026-04-30T10:23:46","slug":"rofaday","status":"publish","type":"product","link":"https:\/\/medsbase.com\/cs\/product\/rofaday\/","title":{"rendered":"Rofaday"},"content":{"rendered":"<div class=\"medsbase-tldr-answer\" style=\"background:#fff8e1;border-left:4px solid #f5a623;padding:18px 22px;margin:0 0 28px 0;border-radius:4px;\">\n<h3 style=\"margin:0 0 10px 0;font-size:18px;color:#1a1a1a;\">\u26a1 Rychl\u00e1 odpov\u011b\u010f \u2014 Co je Rofaday?<\/h3>\n<p><strong>Rofaday<\/strong> obsahuje <strong>roflumilast 500 mcg<\/strong>, , <strong>or\u00e1ln\u00ed selektivn\u00ed inhibitor fosfodiester\u00e1zy-4 (PDE4)<\/strong> u\u017e\u00edvan\u00fd jednou denn\u011b pro <strong>t\u011b\u017ekou chronickou obstruk\u010dn\u00ed plicn\u00ed nemoc (CHOPN) s fenotypem chronick\u00e9 bronchitidy a \u010dast\u00fdmi exacerbacemi<\/strong>. Roflumilast m\u00e1 protiz\u00e1n\u011btliv\u00fd \u00fa\u010dinek sp\u00ed\u0161e ne\u017e bronchodilata\u010dn\u00ed \u2014 potla\u010duje aktivaci neutrofil\u016f a makrof\u00e1g\u016f v d\u00fdchac\u00edch cest\u00e1ch, co\u017e v kl\u00ed\u010dov\u00fdch studi\u00edch (M2-124, M2-125, REACT) sn\u00ed\u017eilo frekvenci exacerbac\u00ed p\u0159ibli\u017en\u011b o 17%. P\u0159id\u00e1v\u00e1 se k optim\u00e1ln\u00ed terapii LAMA + LABA (\u00b1 ICS) u pacient\u016f s t\u011b\u017ek\u00fdm onemocn\u011bn\u00edm. V\u00fdrobce: <strong>Cipla<\/strong>.<\/p>\n<\/div>\n<div class=\"medsbase-trust-strip\" style=\"background:#f4f8fb;border:1px solid #d8e3eb;padding:12px 16px;margin:16px 0;border-radius:4px;font-size:14px;\">\n<strong>Co z\u00edsk\u00e1te s MedsBase:<\/strong> V\u00fdrobce certifikovan\u00fd WHO-GMP \u00b7 Diskr\u00e9tn\u00ed balen\u00ed \u00b7 Celosv\u011btov\u00e1 doprava \u00b7 V\u00edce ne\u017e 1 400 ov\u011b\u0159en\u00fdch <a href=\"https:\/\/medsbase.com\/cs\/reviews\/\">recenz\u00ed z\u00e1kazn\u00edk\u016f<\/a>\n<\/div>\n<p class=\"medsbase-reship-line\" style=\"font-size:14px;color:#444;margin:8px 0 18px;\">\ud83d\udce6 Ka\u017ed\u00e1 objedn\u00e1vka je pokryta na\u0161\u00ed <a href=\"https:\/\/medsbase.com\/cs\/medsbase-re-shipment-assurance-policy\/\"><strong>Z\u00e1rukou op\u011btovn\u00e9ho odesl\u00e1n\u00ed<\/strong><\/a> \u2014 pokud va\u0161e z\u00e1silka nedoraz\u00ed do 20 pracovn\u00edch dn\u016f, p\u0159epos\u00edl\u00e1me ji.<\/p>\n<h3>Pro\u010d objedn\u00e1vat z MedsBase<\/h3>\n<p>Na\u0161e generick\u00e9 l\u00e9ky poch\u00e1zej\u00ed od v\u00fdrobc\u016f certifikovan\u00fdch WHO-GMP a jsou expedov\u00e1ny po cel\u00e9m sv\u011bt\u011b v diskr\u00e9tn\u00edm, nen\u00e1padn\u00e9m balen\u00ed \u2013 na vn\u011bj\u0161\u00ed stran\u011b bal\u00edku nen\u00ed uveden n\u00e1zev l\u00e9ku. Platby kartou jsou sm\u011brov\u00e1ny prost\u0159ednictv\u00edm regulovan\u00e9ho procesoru (popisky na v\u00fdpisu zahrnuj\u00ed regulovan\u00e9ho procesora plateb kartou \u2013 nikdy \u201cMedsBase\u201d nebo n\u00e1zev l\u00e9ku). P\u0159ij\u00edm\u00e1me tak\u00e9 kryptom\u011bny a bankovn\u00ed p\u0159evody SEPA. Ka\u017ed\u00e1 objedn\u00e1vka je zaji\u0161t\u011bna na\u0161\u00ed politikou p\u0159eposl\u00e1n\u00ed.<\/p>\n<div style=\"background:#f4f8fb;border:1px solid #e0e0e0;padding:12px 18px;margin:0 0 24px 0;border-radius:4px;font-size:14px;text-align:center;\">\n<strong>\ud83d\udd12 \u0160ifrovan\u00fd n\u00e1kup<\/strong> \u00b7 <strong>\ud83d\udcb3 Ov\u011b\u0159en\u00fd procesor<\/strong> \u00b7 <strong>\ud83d\ude9a Doprava po cel\u00e9m sv\u011bt\u011b<\/strong> \u00b7 <strong>\u2b50 4,9\/5 od 1 400+ z\u00e1kazn\u00edk\u016f<\/strong>\n<\/div>\n<h2>Co je Rofaday?<\/h2>\n<p>Rofaday je or\u00e1ln\u00ed inhibitor PDE4 pro t\u011b\u017ekou CHOPN. Roflumilast je jedin\u00fd inhibitor PDE4 schv\u00e1len\u00fd pro CHOPN \u2014 na mezin\u00e1rodn\u00edm trhu prod\u00e1van\u00fd jako Daxas (AstraZeneca) a Daliresp. Jde o specializovan\u00fd, ale dob\u0159e prok\u00e1zan\u00fd dopln\u011bk l\u00e9\u010dby u fenotypu chronick\u00e9 bronchitidy.<\/p>\n<h2>Jak Rofaday funguje?<\/h2>\n<p>Fosfodiester\u00e1za-4 (PDE4) je hlavn\u00ed enzym degraduj\u00edc\u00ed cyklick\u00fd AMP v z\u00e1n\u011btliv\u00fdch bu\u0148k\u00e1ch (neutrofily, makrof\u00e1gy, eosinofily, T-lymfocyty). Inhibice PDE4 zvy\u0161uje hladinu cyklick\u00e9ho AMP v t\u011bchto bu\u0148k\u00e1ch, \u010d\u00edm\u017e potla\u010duje:<\/p>\n<ul>\n<li>Chemotaxi neutrofil\u016f a jejich degranulaci v d\u00fdchac\u00edch cest\u00e1ch<\/li>\n<li>Uvol\u0148ov\u00e1n\u00ed cytokin\u016f z makrof\u00e1g\u016f (TNF-\u03b1, IL-8)<\/li>\n<li>Proliferaci hladk\u00e9ho svalstva d\u00fdchac\u00edch cest a aktivaci fibroblast\u016f<\/li>\n<li>Hypersekreci hlenu a hyperplazii poh\u00e1rkov\u00fdch bun\u011bk<\/li>\n<\/ul>\n<p>Klinick\u00fdm v\u00fdsledkem je 15\u201317% sn\u00ed\u017een\u00ed m\u00edry exacerbac\u00ed CHOPN p\u0159i p\u0159id\u00e1n\u00ed k optim\u00e1ln\u00ed inhala\u010dn\u00ed terapii.<\/p>\n<h2>Pou\u017eit\u00ed a indikace<\/h2>\n<ul>\n<li><strong>T\u011b\u017ek\u00e1 CHOPN (FEV1 &lt;50% predikovan\u00e9 hodnoty) s chronickou bronchitidou<\/strong> a anamn\u00e9zou exacerbac\u00ed, nav\u00edc k optim\u00e1ln\u00ed terapii LAMA + LABA (\u00b1 ICS)<\/li>\n<li><strong>\u010cast\u00fd exacerb\u00e1torov\u00fd fenotyp<\/strong> s p\u0159etrv\u00e1vaj\u00edc\u00edm produktivn\u00edm ka\u0161lem<\/li>\n<\/ul>\n<h2>D\u00e1vkov\u00e1n\u00ed p\u0159\u00edpravku Rofaday<\/h2>\n<table style=\"border-collapse:collapse;width:100%;margin:12px 0;\">\n<thead>\n<tr style=\"background:#2c7cb0;color:#fff;\">\n<th style=\"padding:10px;border:1px solid #ddd;text-align:left;\">Pacient<\/th>\n<th style=\"padding:10px;border:1px solid #ddd;text-align:left;\">D\u00e1vka<\/th>\n<th style=\"padding:10px;border:1px solid #ddd;text-align:left;\">Frekvence<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"padding:10px;border:1px solid #ddd;\">Dosp\u011bl\u00ed \u2014 za\u010dn\u011bte<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\"><strong>250 mcg<\/strong> po\u010d\u00e1te\u010dn\u00edch 4 t\u00fddn\u016f<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Jednou denn\u011b<\/td>\n<\/tr>\n<tr style=\"background:#f9f9f9;\">\n<td style=\"padding:10px;border:1px solid #ddd;\">Dosp\u011bl\u00ed \u2014 udr\u017eovac\u00ed d\u00e1vka<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\"><strong>500 mcg<\/strong><\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Jednou denn\u011b, s j\u00eddlem nebo bez j\u00eddla<\/td>\n<\/tr>\n<tr>\n<td style=\"padding:10px;border:1px solid #ddd;\">Porucha funkce jater<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Vyvarujte se (Child-Pugh B\/C)<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">\u2014<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2>Vedlej\u0161\u00ed \u00fa\u010dinky p\u0159\u00edpravku Rofaday<\/h2>\n<ul>\n<li><strong>\u00dabytek hmotnosti<\/strong> (pr\u016fm\u011brn\u011b 2\u20133 kg ve studi\u00edch \u2014 sledujte; reverzujte pokud &gt;5%)<\/li>\n<li>Pr\u016fjem, nevolnost (nej\u010dast\u011bj\u0161\u00ed d\u016fvod k ukon\u010den\u00ed l\u00e9\u010dby; obvykle ustoup\u00ed po prvn\u00edch 2\u20134 t\u00fddnech)<\/li>\n<li>Bolest hlavy<\/li>\n<li>Nespavost, \u00fazkost<\/li>\n<li>Dyspepsie, bolesti b\u0159icha<\/li>\n<li>Zm\u011bny n\u00e1lady \u2014 deprese, \u00fazkost; vz\u00e1cn\u011b sebevra\u017eedn\u00e9 my\u0161lenky (varov\u00e1n\u00ed)<\/li>\n<\/ul>\n<p><strong>Z\u00e1va\u017en\u00e9 \u2014 p\u0159esta\u0148te u\u017e\u00edvat a vyhledejte pomoc:<\/strong><\/p>\n<ul>\n<li>V\u00fdrazn\u00fd \u00fabytek hmotnosti (&gt;5% t\u011blesn\u00e9 hmotnosti)<\/li>\n<li>Nov\u011b vznikl\u00e9 nebo zhor\u0161en\u00e9 deprese, sebevra\u017eedn\u00e9 my\u0161lenky<\/li>\n<li>T\u011b\u017ek\u00e1 p\u0159etrv\u00e1vaj\u00edc\u00ed pr\u016fjem<\/li>\n<li>Z\u00e1va\u017en\u00e1 alergick\u00e1 reakce<\/li>\n<\/ul>\n<h2>Varov\u00e1n\u00ed a opat\u0159en\u00ed<\/h2>\n<ul>\n<li><strong>N\u00e1lada a chov\u00e1n\u00ed:<\/strong> p\u0159ed zah\u00e1jen\u00edm l\u00e9\u010dby vy\u0161et\u0159it na depresi; upozornit pacienty\/rodiny, aby hl\u00e1sili nov\u00e9 p\u0159\u00edznaky zm\u011bny n\u00e1lady.<\/li>\n<li><strong>\u00dabytek hmotnosti:<\/strong> monitorov\u00e1n\u00ed hmotnosti na za\u010d\u00e1tku a ka\u017ed\u00e9 3 m\u011bs\u00edce; pokud \u00fabytek p\u0159es\u00e1hne 5%, p\u0159ehodnotit nebo ukon\u010dit l\u00e9\u010dbu.<\/li>\n<li><strong>Porucha funkce jater:<\/strong> vyvarovat se u pacient\u016f s Child-Pugh B a C.<\/li>\n<li><strong>4t\u00fddenn\u00ed titrace d\u00e1vky<\/strong> (250 mcg) sni\u017euje gastrointestin\u00e1ln\u00ed ne\u017e\u00e1douc\u00ed \u00fa\u010dinky a pr\u016fjem \u2014 v\u011bt\u0161ina pacient\u016f pak snese 500 mcg.<\/li>\n<li><strong>Nen\u00ed bronchodilatans<\/strong> \u2014 nenahrazuje LAMA, LABA ani ICS.<\/li>\n<li><strong>T\u011bhotenstv\u00ed a kojen\u00ed:<\/strong> kontraindikov\u00e1no.<\/li>\n<li><strong>Interakce s l\u00e9ky:<\/strong> Induktory CYP3A4 (rifampicin) sni\u017euj\u00ed hladiny \u2014 vyvarujte se. Siln\u00e9 inhibitory CYP1A2 (fluvoxamin, ciprofloxacin) zvy\u0161uj\u00ed hladiny \u2014 opatrnost.<\/li>\n<\/ul>\n<h2>Kontraindikace<\/h2>\n<ul>\n<li>P\u0159ecitliv\u011blost na roflumilast<\/li>\n<li>St\u0159edn\u011b t\u011b\u017ek\u00e9 a\u017e t\u011b\u017ek\u00e9 po\u0161kozen\u00ed jater (Child-Pugh B\/C)<\/li>\n<li>T\u011bhotenstv\u00ed<\/li>\n<\/ul>\n<h2>Interakce s l\u00e9\u010divy<\/h2>\n<table style=\"border-collapse:collapse;width:100%;margin:12px 0;\">\n<thead>\n<tr style=\"background:#2c7cb0;color:#fff;\">\n<th style=\"padding:10px;border:1px solid #ddd;text-align:left;\">Interaguj\u00edc\u00ed l\u00e9k<\/th>\n<th style=\"padding:10px;border:1px solid #ddd;text-align:left;\">\u00da\u010dinek<\/th>\n<th style=\"padding:10px;border:1px solid #ddd;text-align:left;\">Co d\u011blat<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"padding:10px;border:1px solid #ddd;\">Induktory CYP3A4 (rifampicin, fenobarbital, fenytoin, karbamazepin)<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Sni\u017euj\u00ed hladiny roflumilastu o 50 %<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Vyhnout se<\/td>\n<\/tr>\n<tr style=\"background:#f9f9f9;\">\n<td style=\"padding:10px;border:1px solid #ddd;\">Siln\u00e9 inhibitory CYP1A2 (fluvoxamin, ciprofloxacin, enoxacin)<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Zvy\u0161uj\u00ed hladiny roflumilastu \u2014 vy\u0161\u0161\u00ed riziko vedlej\u0161\u00edch \u00fa\u010dink\u016f<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Opatrnost; zva\u017ete ni\u017e\u0161\u00ed d\u00e1vku<\/td>\n<\/tr>\n<tr>\n<td style=\"padding:10px;border:1px solid #ddd;\">Peror\u00e1ln\u00ed antikoncepce obsahuj\u00edc\u00ed gestoden<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">M\u00edrn\u00e9 zv\u00fd\u0161en\u00ed hladin roflumilastu<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Obvykle nen\u00ed nutn\u00e1 \u00faprava d\u00e1vky<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2>Skladov\u00e1n\u00ed<\/h2>\n<ul>\n<li>Skladujte p\u0159i teplot\u011b do <strong>25\u00b0C<\/strong> na chladn\u00e9m, such\u00e9m m\u00edst\u011b, chr\u00e1n\u011bn\u00e9m p\u0159ed p\u0159\u00edm\u00fdm slune\u010dn\u00edm z\u00e1\u0159en\u00edm.<\/li>\n<li>Ponechte v p\u016fvodn\u00edm obalu a\u017e do pou\u017eit\u00ed, aby byl chr\u00e1n\u011bn p\u0159ed vlhkost\u00ed a sv\u011btlem.<\/li>\n<li>Nepou\u017e\u00edvejte po uplynut\u00ed data expirace uveden\u00e9ho na blistru.<\/li>\n<li>Uchov\u00e1vejte mimo dosah d\u011bt\u00ed.<\/li>\n<\/ul>\n<h2>Souvisej\u00edc\u00ed alternativy na MedsBase<\/h2>\n<ul>\n<li><a href=\"https:\/\/medsbase.com\/cs\/asthalin-inhaler\/\"><strong>Asthalin Inhaler \u2014 salbutamol \u00falevov\u00fd inhal\u00e1tor<\/strong><\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/cs\/budecort-inhaler\/\"><strong>Budecort Inhaler \u2014 budesonid preventivn\u00ed ICS inhal\u00e1tor<\/strong><\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/cs\/foracort-inhaler\/\"><strong>Foracort Inhaler \u2014 budesonid + formoterol ICS-LABA inhal\u00e1tor<\/strong><\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/cs\/tiova-inhaler\/\"><strong>Tiova Inhaler \u2014 tiotropium LAMA pro CHOPN<\/strong><\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/cs\/montair\/\"><strong>Montair \u2014 montelukast LTRA tablety<\/strong><\/a><\/li>\n<\/ul>\n<h2 id=\"faqs\">\u010casto kladen\u00e9 dotazy<\/h2>\n<h3>Kdy se p\u0159id\u00e1v\u00e1 Rofaday?<\/h3>\n<p>U t\u011b\u017ek\u00e9 CHOPN (FEV1 &lt;50 % predikovan\u00fdch hodnot) s fenotypem chronick\u00e9 bronchitidy a anamn\u00e9zou \u010dast\u00fdch exacerbac\u00ed navzdory optim\u00e1ln\u00ed l\u00e9\u010db\u011b LAMA + LABA (\u00b1 ICS). Nen\u00ed ur\u010deno pro m\u00edrnou CHOPN nebo astma.<\/p>\n<h3>Pro\u010d mus\u00edm za\u010d\u00edt d\u00e1vkou 250 mcg?<\/h3>\n<p>4t\u00fddenn\u00ed titrace 250 mcg v\u00fdrazn\u011b sni\u017euje gastrointestin\u00e1ln\u00ed ne\u017e\u00e1douc\u00ed \u00fa\u010dinky (pr\u016fjem, nevolnost) \u2014 v\u011bt\u0161ina pacient\u016f pak m\u016f\u017ee p\u0159ej\u00edt na udr\u017eovac\u00ed d\u00e1vku 500 mcg bez intolerance.<\/p>\n<h3>O kolik Rofaday sni\u017euje exacerbace?<\/h3>\n<p>P\u0159ibli\u017en\u011b 15\u201317% sn\u00ed\u017een\u00ed st\u0159edn\u011b t\u011b\u017ek\u00fdch a\u017e t\u011b\u017ek\u00fdch exacerbac\u00ed CHOPN v kl\u00ed\u010dov\u00fdch studi\u00edch (M2-124, M2-125, REACT). Nejv\u011bt\u0161\u00ed benefit byl pozorov\u00e1n u fenotypu chronick\u00e9 bronchitidy s \u010dast\u00fdmi exacerbacemi.<\/p>\n<h3>Zp\u016fsob\u00ed Rofaday \u00fabytek hmotnosti?<\/h3>\n<p>Ano \u2014 pr\u016fm\u011brn\u011b 2\u20133 kg ve studi\u00edch. Monitorujte hmotnost na za\u010d\u00e1tku a ka\u017ed\u00e9 3 m\u011bs\u00edce. Pokud \u00fabytek p\u0159es\u00e1hne 5%, p\u0159ehodno\u0165te indikaci nebo l\u00e9\u010dbu ukon\u010dete.<\/p>\n<h3>A co zm\u011bny n\u00e1lady?<\/h3>\n<p>Vz\u00e1cn\u00e9, ale hl\u00e1\u0161en\u00e9. Prov\u011b\u0159te depresi na za\u010d\u00e1tku; pou\u010dte pacienta a rodinu, aby hl\u00e1sili nov\u00e9 p\u0159\u00edznaky n\u00e1lady, \u00fazkost nebo sebevra\u017eedn\u00e9 my\u0161lenky. P\u0159eru\u0161te l\u00e9\u010dbu a p\u0159ehodno\u0165te.<\/p>\n<h3>Je Rofaday bronchodilatans?<\/h3>\n<p>Ne \u2014 m\u00e1 pouze protiz\u00e1n\u011btliv\u00fd \u00fa\u010dinek. Pokra\u010dujte v u\u017e\u00edv\u00e1n\u00ed LAMA, LABA a (kde je indikov\u00e1no) ICS inhal\u00e1tor\u016f.<\/p>\n<h3>Mohu u\u017e\u00edvat Rofaday b\u011bhem t\u011bhotenstv\u00ed?<\/h3>\n<p>Kontraindikov\u00e1no.<\/p>\n<h3>Jak se Rofaday srovn\u00e1v\u00e1 s trojkombinac\u00ed?<\/h3>\n<p>Trojkombinace (Triohale) a Rofaday \u0159e\u0161\u00ed exacerbace CHOPN r\u016fzn\u00fdmi mechanismy (bronchodilatace + potla\u010den\u00ed z\u00e1n\u011btu vs. PDE4-zprost\u0159edkovan\u00e1 protiz\u00e1n\u011btliv\u00e1 l\u00e9\u010dba). N\u011bkte\u0159\u00ed pacienti maj\u00ed prosp\u011bch z obou.<\/p>\n<h3>Jak\u00e9 jsou nejd\u016fle\u017eit\u011bj\u0161\u00ed l\u00e9kov\u00e9 interakce?<\/h3>\n<p>Rifampicin (a dal\u0161\u00ed induktory CYP3A4) sni\u017euj\u00ed hladinu Rofaday na polovinu \u2014 vyvarujte se. Siln\u00e9 inhibitory CYP1A2 (fluvoxamin, ciprofloxacin) zvy\u0161uj\u00ed hladiny \u2014 opatrnost.<\/p>\n<div style=\"background:#fff3f3;border-left:4px solid #d9534f;padding:14px 18px;margin:24px 0;border-radius:4px;font-size:13px;\"><strong>Zdravotn\u00ed upozorn\u011bn\u00ed:<\/strong> Tato str\u00e1nka je vzd\u011bl\u00e1vac\u00ed a nenahrazuje odbornou l\u00e9ka\u0159skou pomoc. P\u0159ed zah\u00e1jen\u00edm, ukon\u010den\u00edm nebo zm\u011bnou jak\u00e9hokoli inhal\u00e1toru nebo respira\u010dn\u00edho l\u00e9ku se v\u017edy pora\u010fte s kvalifikovan\u00fdm zdravotnick\u00fdm pracovn\u00edkem, zejm\u00e9na pokud m\u00e1te jin\u00e9 zdravotn\u00ed pot\u00ed\u017ee, u\u017e\u00edv\u00e1te jin\u00e9 l\u00e9ky, jste t\u011bhotn\u00e1 nebo koj\u00edte, nebo je v\u00e1m v\u00edce ne\u017e 65 let.<\/div>\n<p><!-- medsbase-related-alts-v1 --><\/p>\n<h3 class=\"wp-block-heading\">Souvisej\u00edc\u00ed alternativy<\/h3>\n<p>Dal\u0161\u00ed produkty v <strong>Chronick\u00e1 onemocn\u011bn\u00ed<\/strong> kter\u00e9 z\u00e1kazn\u00edci tak\u00e9 prohl\u00ed\u017eej\u00ed:<\/p>\n<ul>\n<li><a href=\"https:\/\/medsbase.com\/cs\/glycomet-gp\/\">Glycomet-GP<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/cs\/loratin\/\">Loratin<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/cs\/lasix\/\">Lasix<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/cs\/decdan\/\">Decdan<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/cs\/hydrocl\/\">Hydrocl<\/a><\/li>\n<\/ul>","protected":false},"excerpt":{"rendered":"<p>\u2705 Sni\u017euje z\u00e1n\u011bt plic<br \/>\n\u2705 Zlep\u0161uje funkci plic<br \/>\n\u2705 L\u00e9\u010d\u00ed chronickou bronchitidu<br \/>\n\u2705 Sni\u017euje exacerbace CHOPN<br \/>\n\u2705 Zlep\u0161uje dechovou kapacitu<\/p>\n<p>Rofaday obsahuje Roflumilast.<\/p>","protected":false},"featured_media":60488,"comment_status":"open","ping_status":"open","template":"","meta":[],"product_brand":[],"product_cat":[3681,3141,3223],"product_tag":[4868,4869],"class_list":{"0":"post-60487","1":"product","2":"type-product","3":"status-publish","4":"has-post-thumbnail","6":"product_cat-asthma-copd-treatment","7":"product_cat-category-overview","8":"product_cat-chronic-conditions","9":"product_tag-rofaday","10":"product_tag-roflumilast","12":"first","13":"instock","14":"shipping-taxable","15":"purchasable","16":"product-type-variable","17":"has-default-attributes"},"acf":[],"_links":{"self":[{"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/product\/60487","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/comments?post=60487"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/media\/60488"}],"wp:attachment":[{"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/media?parent=60487"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/product_brand?post=60487"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/product_cat?post=60487"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/product_tag?post=60487"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}